Article Details

Bicycle Therapeutics (NASDAQ:BCYC) Stock Rating Upgraded by Goldman Sachs Group

Retrieved on: 2019-08-24 01:26:15

Tags for this article:

Click the tags to see associated articles and topics

Bicycle Therapeutics (NASDAQ:BCYC) Stock Rating Upgraded by Goldman Sachs Group. View article details on HISWAI:

Excerpt

<div><b>Atlas Venture</b> Advisors Inc. acquired a new stake in Bicycle Therapeutics during the second quarter worth $13,709,000. Victory Capital Management ...</div>

Article found on:

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up